Developer docs
API playgroundTry for free, no card

Search company profiles

Vygon

Full company profile

uuid0009lqb

Namestring
Vygon
Legal namestring
Vygon, Société Anonyme Simplifiée au capital de 19 463 088 €
Websiteurl
vygon.com
Company typeenum
Private
Founded yearint
1962
Descriptiontext

Vygon is a French-headquartered, privately held medical device manufacturer founded in 1962 that designs and produces sterile single-use and electronic medical devices organized into seven therapeutic categories: vascular access, enteral feeding, hemodynamic monitoring, regional anesthesia and pain management, respiratory care, surgical consumables, and urinary care. Its portfolio spans acute dialysis catheters, central and peripheral venous catheters, PICC lines, midlines, implantable ports, neonatal-specific feeding systems (Nutrisafe2, celebrating a 20-year heritage in 2026), ISO 80369-3 / 80369-6 compliant safety connectors (ENFit/Nutrifit, NRFit), nerve block and epidural delivery systems, endotracheal tubes and Boussignac CPAP accessories, and the MostCare Up hemodynamic monitor. The company invests approximately 5% of revenue into R&D through a 60-person team operating across four development centers in France and Germany, supported by a portfolio of 183 globally filed patents.

Vygon produces roughly 210 million medical devices per year from predominantly European factories in Écouen (SIPV, SIPA), Belgium (Dimequip), and Germany, and sells through 26 wholly-owned subsidiaries and complementary distribution partners serving healthcare facilities in over 120 countries. Revenue is generated almost entirely through B2B hardware sales of single-use devices under quote-based, multi-year procurement contracts negotiated with hospitals, clinical departments, and group purchasing organizations; no consumer-facing pricing is published. The company employs 2,783 people globally and is led by CEO Ludovic Richard-Vitton and Chairman Stéphane Regnault, with CFO Anne Najaint and a broader executive team overseeing strategy, manufacturing, operations, and international deployment.

FY2025 reported revenue was €423 million, reflecting the cumulative scale of organic expansion and a steady M&A track record (Perouse Medical 2015, Advanced Perfusion Diagnostics 2020, Macatt Medica 2022, Stiletto 2026). Co-development partnerships with Institut Curie (oncology safety devices, Qimono line) and Carmat (artificial heart connectivity) extend the company's specialization into adjacent safety-critical niches, while management rotations in the UK and German subsidiaries during 2026 signal continued investment in commercial leadership across its two largest European markets.

Short descriptiontext

Vygon is a French-headquartered, privately held medical device manufacturer (founded 1962) that designs and produces sterile single-use devices across vascular access, enteral feeding, anesthesia, respiratory, surgical, urinary, and monitoring categories, serving hospitals in over 120 countries via 26 subsidiaries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersÉcouen, France
HQ citystring
Écouen
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices11 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
single-use medical devices, vascular access catheters, enteral feeding systems, regional anesthesia devices, sterile medical devices
Industry3 codes
PRIMARYHLAHADAA
Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYCRADAMAK
Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYHSABAKAH
Incontinence & Urological Supplies (Catheters, Briefs, Ostomy Supplies)
Home & Personal Services/Elder Care & In-Home Care Services/Medical Equipment & Home Mobility Support Services
NAICS code3 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Surgical Appliance and Supplies Manufacturing339113
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Single-Use Medical Devices
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Medical Device Sales
TypeHardware Sales
Description

Vygon generates revenue primarily through the sale of sterile single-use and electronic medical devices across multiple therapeutic categories including vascular access, enteral feeding, respiratory, surgical, and monitoring solutions. Products are sold directly through subsidiaries and distribution networks to healthcare facilities worldwide.

be.vygon.com
2Product Portfolio Diversification
TypeHardware Sales
Description

Revenue streams span seven major product categories: Vascular, Enteral, Monitoring, Nervous, Respiratory, Surgery, and Urinary, providing diversified revenue across therapeutic areas and reducing dependency on any single product line.

be.vygon.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales
Pricing details1 tier
1B2B healthcare facility pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Quote-based pricing through healthcare procurement and group purchasing organization relationships. No consumer-facing pricing available.

vygon.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1Nutrisafe2
Description

Safety enteral feeding system for neonates and preemies, celebrating 20th anniversary in 2026

vygon.com
+5 more records
Core offering1 text field

Vygon designs, manufactures, and sells sterile single-use and electronic medical devices organized into seven therapeutic categories: vascular access, enteral feeding, hemodynamic monitoring, nervous system (regional anesthesia), respiratory, surgery, and urinary care. The company produces over 210 million medical devices annually from European manufacturing facilities and serves healthcare professionals in more than 120 countries through 26 subsidiaries. Products are targeted at hospital systems and clinical departments for use in patient care from neonates to adults.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 210 million medical devices produced annually from European manufacturing
+2 more records
Product overview1 text field

Vygon designs and manufactures sterile single-use and electronic medical devices. The company operates as a global medical device manufacturer with a diversified product portfolio organized into seven core categories: Vascular Access (including acute dialysis catheters, CVCs, PICC lines, midlines, implantable ports, and infusion therapy), Enteral Feeding (with ENFit/Nutrifit safety systems and Nutrisafe2 for neonates), Hemodynamic Monitoring (MostCare Up), Nervous System/Anesthesia products, Respiratory/Ventilation products, Surgery supplies, and Urinary care products. Vygon produces over 210 million medical devices annually across its European-focused manufacturing sites, with 26 subsidiaries serving customers in over 120 countries. The company emphasizes product safety, innovation (183 patents filed), and specialized solutions for vulnerable patient populations including neonates and pediatrics.

Product and service10 records
1Vascular Access Products
CategoryVascular Access
Description

A comprehensive range of sterile single-use devices for short, medium, and long-term access to the peripheral and central vascular system, serving patients from newborns to adults. Includes acute dialysis catheters, adult and pediatric central venous catheters (CVC), arterial catheters, PICC lines, midlines, implantable ports, Huber needles, peripheral IV catheters, tunneled CICC, securement devices, dressings, stimulating catheters, and IV accessories for oncology.

2Enteral Feeding Products
CategoryEnteral Nutrition
Description

Feeding tubes and systems for patients from neonates to adults, including safety connectors (ENFit/Nutrifit), non-safety feeding systems, Nutrisafe2 systems for neonates/preemies, and feeding pumps and sets. Designed for safe enteral nutrition delivery and prevention of misconnections.

3MostCare Up
CategoryHemodynamic Monitoring
Description

Hemodynamic monitoring solution for real-time patient management, providing monitoring capabilities for hemodynamic assessment of the patient.

4Nervous System (Regional Anesthesia) Products
CategoryRegional Anesthesia and Pain Management
Description

Products for regional anesthesia delivery and pain management, including epidural anesthesia, spinal anesthesia, plexus and peripheral nerve blocks. Includes accessories for regional anaesthesia, cryotherapy, PCA (Patient Controlled Analgesia), NRFit secure range, standard LUER range, and Vysets custom sets.

5Respiratory Products
CategoryRespiratory Care
Description

Products for both invasive ventilation (endotracheal tubes from neonates to adults, suction catheters, mucus extractors) and non-invasive ventilation (oxygen therapy, Boussignac CPAP accessories). Also includes connectors, facial masks, intubation accessories, thoracic drainage, tracheal suction tubes, and protected bronchial sampling.

6Surgery Products
CategorySurgical Supplies
Description

Surgical consumables for operating room procedures including drapes, gowns, patient asepsis products, cyanoacrylate glue for wound closure, surgical suction and wound drainage systems, suture materials, and hygiene products.

7Urinary Care Products
CategoryUrinary Care
Description

Products for urinary catheterization and monitoring, including vesical catheters, hourly diuresis monitoring systems, and vesical lavage equipment.

8Nutrisafe2 Safety Enteral Feeding System
CategoryEnteral Nutrition
Description

A safety enteral feeding system specifically designed for neonates and premature babies with dedicated medical devices addressing the unique physiological needs of neonatal patients due to their tiny size and immaturity. Features specialized connectors to prevent misconnections.

9ENFit / Nutrifit Feeding Systems
CategoryEnteral Nutrition
Description

Safety enteral feeding connectors designed to prevent misconnections with other medical devices, meeting ISO 80369-3 standard for adult patients. ENFit is the global standard for enteral nutrition connections.

10Stiletto Extended-Dwell Catheter
CategoryVascular Access
Description

A next-generation extended-dwell catheter acquired by Vygon in February 2026. Designed for smooth, guidewire-free insertion and enhanced patient comfort, strengthening Vygon's vascular access leadership.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic collaboration with Institut Curie to develop new safety standards for oncology devices. This partnership resulted in the creation of the Qimono product line, which provides safety devices protecting medical staff exposed to cytotoxic drug toxicity during oncology treatments.

2Carmat
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership with Carmat to develop high-precision connectivity solutions for artificial heart devices. Vygon contributes its expertise in medical device connectors and manufacturing to complement Carmat's artificial heart technology.

be.vygon.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

BD is a broad-line medical device incumbent competing with Vygon in vascular access (PICC/midlines), surgical disposables, and respiratory products, with deeper U.S. footprint and broader GPO contracts.

2Medline Industries
TypeBroad incumbent
Description

Medline is a large private medical supply manufacturer with adjacent categories including surgical drapes/gowns, vascular access accessories, and urinary care, competing with Vygon's surgical and consumables lines primarily through U.S. distribution.

TypeBroad incumbent
Description

B. Braun is a larger diversified medical device incumbent with substantial overlap in IV therapy, regional anesthesia, vascular access, and infusion systems, competing against Vygon across most of its seven therapeutic categories.

TypeDirect peer
Description

Teleflex is a direct peer across vascular access, anesthesia, and respiratory single-use devices, mirroring Vygon's portfolio in catheters, epidural/spinal anesthesia, and airway management with comparable enterprise sales motion to hospitals globally.

TypeBroad incumbent
Description

Fresenius Kabi is a broad medical device and infusion therapy incumbent overlapping Vygon's vascular access, enteral nutrition, and infusion product lines, particularly in European hospital channels.

TypeDirect peer
Description

ICU Medical (post Smiths Medical integration) directly overlaps Vygon's vascular access, IV therapy, and enteral feeding categories, serving the same hospital customers with similar disposable medical device portfolios and GPO-style procurement.

7Cook Medical
TypeDirect peer
Description

Cook Medical directly competes with Vygon in vascular access and enteral feeding devices, particularly catheters and specialty access products, with similar hospital-focused enterprise sales motion.

TypeEmerging player
Description

Amsino is an emerging player in single-use medical devices including urinary catheters, IV therapy, and enteral feeding products, providing lower-cost competition to Vygon particularly in non-European markets.

9GBUK Group
TypeEmerging player
Description

GBUK Group is a UK-based specialist in enteral feeding and vascular access devices with partial overlap to Vygon's Nutrisafe2 and ENFit portfolios, competing primarily in the UK hospital market segment.

10Smiths Medical (now ICU Medical)
TypeDirect peer
Description

Smiths Medical (acquired by ICU Medical in 2024) historically overlapped directly with Vygon in vascular access, enteral feeding, and respiratory/anesthesia disposables with comparable product breadth and hospital sales channels.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment8 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries17 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Vygon

Single-Use Medical Devicesvygon.com

Vygon is a French-headquartered, privately held medical device manufacturer (founded 1962) that designs and produces sterile single-use devices across vascular access, enteral feeding, anesthesia, respiratory, surgical, urinary, and monitoring categories, serving hospitals in over 120 countries via 26 subsidiaries.

What Vygon does

Vygon is a French-headquartered, privately held medical device manufacturer founded in 1962 that designs and produces sterile single-use and electronic medical devices organized into seven therapeutic categories: vascular access, enteral feeding, hemodynamic monitoring, regional anesthesia and pain management, respiratory care, surgical consumables, and urinary care. Its portfolio spans acute dialysis catheters, central and peripheral venous catheters, PICC lines, midlines, implantable ports, neonatal-specific feeding systems (Nutrisafe2, celebrating a 20-year heritage in 2026), ISO 80369-3 / 80369-6 compliant safety connectors (ENFit/Nutrifit, NRFit), nerve block and epidural delivery systems, endotracheal tubes and Boussignac CPAP accessories, and the MostCare Up hemodynamic monitor. The company invests approximately 5% of revenue into R&D through a 60-person team operating across four development centers in France and Germany, supported by a portfolio of 183 globally filed patents.

Vygon produces roughly 210 million medical devices per year from predominantly European factories in Écouen (SIPV, SIPA), Belgium (Dimequip), and Germany, and sells through 26 wholly-owned subsidiaries and complementary distribution partners serving healthcare facilities in over 120 countries. Revenue is generated almost entirely through B2B hardware sales of single-use devices under quote-based, multi-year procurement contracts negotiated with hospitals, clinical departments, and group purchasing organizations; no consumer-facing pricing is published. The company employs 2,783 people globally and is led by CEO Ludovic Richard-Vitton and Chairman Stéphane Regnault, with CFO Anne Najaint and a broader executive team overseeing strategy, manufacturing, operations, and international deployment.

FY2025 reported revenue was €423 million, reflecting the cumulative scale of organic expansion and a steady M&A track record (Perouse Medical 2015, Advanced Perfusion Diagnostics 2020, Macatt Medica 2022, Stiletto 2026). Co-development partnerships with Institut Curie (oncology safety devices, Qimono line) and Carmat (artificial heart connectivity) extend the company's specialization into adjacent safety-critical niches, while management rotations in the UK and German subsidiaries during 2026 signal continued investment in commercial leadership across its two largest European markets.

Vygon firmographics

Firmographics
Name
Vygon
Legal name
Vygon, Société Anonyme Simplifiée au capital de 19 463 088 €
Website
https://vygon.com
Company type
Private
Founded year
1962
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Vygon is a French-headquartered, privately held medical device manufacturer (founded 1962) that designs and produces sterile single-use devices across vascular access, enteral feeding, anesthesia, respiratory, surgical, urinary, and monitoring categories, serving hospitals in over 120 countries via 26 subsidiaries.
Ownership category
akta.pro rank

Vygon industry classification

Industry
Product category
Single-Use Medical Devices
NAICS
Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHADAA
Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYCRADAMAK
Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYHSABAKAH
Incontinence & Urological Supplies (Catheters, Briefs, Ostomy Supplies)
Home & Personal Services/Elder Care & In-Home Care Services/Medical Equipment & Home Mobility Support Services

Keywords

  • Single-use medical devices
  • Vascular access catheters
  • Enteral feeding systems
  • Regional anesthesia devices
  • Sterile medical devices

Where Vygon is headquartered

Location

Headquarters

HQ city
Écouen
HQ country
France
HQ region
Europe

Offices11 records

Markets served

Vygon business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

  1. Medical Device Sales: Vygon generates revenue primarily through the sale of sterile single-use and electronic medical devices across multiple therapeutic categories including vascular access, enteral feeding, respiratory, surgical, and monitoring solutions. Products are sold directly through subsidiaries and distribution networks to healthcare facilities worldwide.
  2. Product Portfolio Diversification: Revenue streams span seven major product categories: Vascular, Enteral, Monitoring, Nervous, Respiratory, Surgery, and Urinary, providing diversified revenue across therapeutic areas and reducing dependency on any single product line.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractB2B healthcare facility pricing

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Vygon product offering

Product offering

Core offering

Vygon designs, manufactures, and sells sterile single-use and electronic medical devices organized into seven therapeutic categories: vascular access, enteral feeding, hemodynamic monitoring, nervous system (regional anesthesia), respiratory, surgery, and urinary care. The company produces over 210 million medical devices annually from European manufacturing facilities and serves healthcare professionals in more than 120 countries through 26 subsidiaries. Products are targeted at hospital systems and clinical departments for use in patient care from neonates to adults.

Product overview

Vygon designs and manufactures sterile single-use and electronic medical devices. The company operates as a global medical device manufacturer with a diversified product portfolio organized into seven core categories: Vascular Access (including acute dialysis catheters, CVCs, PICC lines, midlines, implantable ports, and infusion therapy), Enteral Feeding (with ENFit/Nutrifit safety systems and Nutrisafe2 for neonates), Hemodynamic Monitoring (MostCare Up), Nervous System/Anesthesia products, Respiratory/Ventilation products, Surgery supplies, and Urinary care products. Vygon produces over 210 million medical devices annually across its European-focused manufacturing sites, with 26 subsidiaries serving customers in over 120 countries. The company emphasizes product safety, innovation (183 patents filed), and specialized solutions for vulnerable patient populations including neonates and pediatrics.

Differentiator

Problem solved

Functional benefit

Brands

  • Nutrisafe2: Safety enteral feeding system for neonates and preemies, celebrating 20th anniversary in 2026
  • MostCare Up
  • ENFit / Nutrifit
  • Stiletto
  • VascuFirst
  • Campus Vygon

Products and services

  • Vascular Access Products A comprehensive range of sterile single-use devices for short, medium, and long-term access to the peripheral and central vascular system, serving patients from newborns to adults. Includes acute dialysis catheters, adult and pediatric central venous catheters (CVC), arterial catheters, PICC lines, midlines, implantable ports, Huber needles, peripheral IV catheters, tunneled CICC, securement devices, dressings, stimulating catheters, and IV accessories for oncology.
  • Enteral Feeding Products Feeding tubes and systems for patients from neonates to adults, including safety connectors (ENFit/Nutrifit), non-safety feeding systems, Nutrisafe2 systems for neonates/preemies, and feeding pumps and sets. Designed for safe enteral nutrition delivery and prevention of misconnections.
  • MostCare Up Hemodynamic monitoring solution for real-time patient management, providing monitoring capabilities for hemodynamic assessment of the patient.
  • Nervous System (Regional Anesthesia) Products Products for regional anesthesia delivery and pain management, including epidural anesthesia, spinal anesthesia, plexus and peripheral nerve blocks. Includes accessories for regional anaesthesia, cryotherapy, PCA (Patient Controlled Analgesia), NRFit secure range, standard LUER range, and Vysets custom sets.
  • Respiratory Products Products for both invasive ventilation (endotracheal tubes from neonates to adults, suction catheters, mucus extractors) and non-invasive ventilation (oxygen therapy, Boussignac CPAP accessories). Also includes connectors, facial masks, intubation accessories, thoracic drainage, tracheal suction tubes, and protected bronchial sampling.
  • Surgery Products Surgical consumables for operating room procedures including drapes, gowns, patient asepsis products, cyanoacrylate glue for wound closure, surgical suction and wound drainage systems, suture materials, and hygiene products.
  • Urinary Care Products Products for urinary catheterization and monitoring, including vesical catheters, hourly diuresis monitoring systems, and vesical lavage equipment.
  • Nutrisafe2 Safety Enteral Feeding System A safety enteral feeding system specifically designed for neonates and premature babies with dedicated medical devices addressing the unique physiological needs of neonatal patients due to their tiny size and immaturity. Features specialized connectors to prevent misconnections.
  • ENFit / Nutrifit Feeding Systems Safety enteral feeding connectors designed to prevent misconnections with other medical devices, meeting ISO 80369-3 standard for adult patients. ENFit is the global standard for enteral nutrition connections.
  • Stiletto Extended-Dwell Catheter A next-generation extended-dwell catheter acquired by Vygon in February 2026. Designed for smooth, guidewire-free insertion and enhanced patient comfort, strengthening Vygon's vascular access leadership.

Quantifiable outcome

  • 210 million medical devices produced annually from European manufacturing
  • +2 more outcomes

Companies that use Vygon

Customer profile

Named customers3 records

Segments8 records

Ideal customer profiles2 records

Vygon technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

Vygon partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and minor.

  • Institut CuriecoreStrategic or Co-development PartnerStrategic collaboration with Institut Curie to develop new safety standards for oncology devices. This partnership resulted in the creation of the Qimono product line, which provides safety devices protecting medical staff exposed to cytotoxic drug toxicity during oncology treatments.
  • CarmatminorStrategic or Co-development PartnerPartnership with Carmat to develop high-precision connectivity solutions for artificial heart devices. Vygon contributes its expertise in medical device connectors and manufacturing to complement Carmat's artificial heart technology.

Scale indicators9 records

Recent moves7 records

Expansion highlights3 records

Vygon competitors and assessment

Company assessment

Broad incumbents

  • Becton Dickinson (BD): BD is a broad-line medical device incumbent competing with Vygon in vascular access (PICC/midlines), surgical disposables, and respiratory products, with deeper U.S. footprint and broader GPO contracts.
  • Medline Industries: Medline is a large private medical supply manufacturer with adjacent categories including surgical drapes/gowns, vascular access accessories, and urinary care, competing with Vygon's surgical and consumables lines primarily through U.S. distribution.
  • B. Braun Melsungen: B. Braun is a larger diversified medical device incumbent with substantial overlap in IV therapy, regional anesthesia, vascular access, and infusion systems, competing against Vygon across most of its seven therapeutic categories.
  • Fresenius Kabi: Fresenius Kabi is a broad medical device and infusion therapy incumbent overlapping Vygon's vascular access, enteral nutrition, and infusion product lines, particularly in European hospital channels.

Direct peers

  • Teleflex: Teleflex is a direct peer across vascular access, anesthesia, and respiratory single-use devices, mirroring Vygon's portfolio in catheters, epidural/spinal anesthesia, and airway management with comparable enterprise sales motion to hospitals globally.
  • ICU Medical: ICU Medical (post Smiths Medical integration) directly overlaps Vygon's vascular access, IV therapy, and enteral feeding categories, serving the same hospital customers with similar disposable medical device portfolios and GPO-style procurement.
  • Cook Medical: Cook Medical directly competes with Vygon in vascular access and enteral feeding devices, particularly catheters and specialty access products, with similar hospital-focused enterprise sales motion.
  • Smiths Medical (now ICU Medical): Smiths Medical (acquired by ICU Medical in 2024) historically overlapped directly with Vygon in vascular access, enteral feeding, and respiratory/anesthesia disposables with comparable product breadth and hospital sales channels.

Emerging players

  • Amsino International: Amsino is an emerging player in single-use medical devices including urinary catheters, IV therapy, and enteral feeding products, providing lower-cost competition to Vygon particularly in non-European markets.
  • GBUK Group: GBUK Group is a UK-based specialist in enteral feeding and vascular access devices with partial overlap to Vygon's Nutrisafe2 and ENFit portfolios, competing primarily in the UK hospital market segment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Vygon social profiles

Digital presence

Vygon compliance and trust

Trust signal

Compliance5 records

Vygon financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Vygon leadership team

Management profile

Number of profiles

Profiles10 records

Vygon subsidiaries and ownership

Company hierarchy

Subsidiaries17 records

Vygon funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Vygon M&A and investment

M&A and investment

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vygon

What does Vygon do?

Vygon designs, manufactures, and sells sterile single-use and electronic medical devices organized into seven therapeutic categories: vascular access, enteral feeding, hemodynamic monitoring, nervous system (regional anesthesia), respiratory, surgery, and urinary care. The company produces over 210 million medical devices annually from European manufacturing facilities and serves healthcare professionals in more than 120 countries through 26 subsidiaries. Products are targeted at hospital systems and clinical departments for use in patient care from neonates to adults.

Is Vygon a public or private company?

Vygon is a private company. It is classified as unknown and is currently operating.

When was Vygon founded?

Vygon was founded in 1962. It employs 1,001 to 5,000 people.

Where is Vygon based?

Vygon is headquartered in Écouen, France, in the Europe region.

How does Vygon make money?

Two revenue lines are on record. Medical Device Sales are the primary driver. The others are product Portfolio Diversification.

Who are Vygon's main competitors?

Broad incumbents on record are Becton Dickinson (BD), Medline Industries, B. Braun Melsungen and Fresenius Kabi. Direct peers are Teleflex, ICU Medical, Cook Medical and Smiths Medical (now ICU Medical). Emerging players are Amsino International and GBUK Group.

Does Vygon have an API?

No public API is recorded for Vygon.

What industry is Vygon in?

Vygon's product category is Single-Use Medical Devices. Its primary akta.pro industry code is HLAHADAA, Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS), with a secondary code of CRADAMAK, Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business & FinancialVygon obtains CE marking for its Stiletto next-generation extended-dwell peripheral catheterVygon obtained CE marking and UKCA for its Stiletto extended-dwell peripheral catheter, enabling European rollout. The catheter uses SlipStream technology, and the global market is over $3 billion, expected to grow 6-9% annually.Mpo-magAvia Vascular’s Stiletto Purchased by VygonVygon has acquired the Stiletto Extended Dwell Catheter and its associated SlipStream technology from Avia Vascular to expand its vascular access portfolio. This transaction marks Vygon's entry into the extended-dwell catheter segment, a market valued at over $3 billion in 2024 with significant growth potential through 2030. The acquisition aims to strengthen Vygon's position in the United States, which holds the largest revenue share for midline catheters globally.MarketsandMarketsElastomeric Infusion Pumps Market, Industry Size Forecast [Latest]MarketsandMarkets published a market research report projecting the global elastomeric infusion pumps market to grow from USD 1.15 billion in 2025 to USD 1.49 billion by 2030, at a CAGR of 5.3%, driven by rising chronic disease prevalence, aging populations, and increasing demand for home-based care. The report identifies key players including Baxter, B. Braun SE, NIPRO, AVNS, and Vygon, and notes that Asia Pacific is the fastest-growing region, while pain management remains the largest application segment and hospitals the dominant end-use sector.The Times of IndiaVygon unveils Nutrisafe2, feeding system designed for neonates, ET HealthWorldVygon unveiled Nutrisafe2, an enteral feeding system for neonates, to address tubing misconnections. The launch responds to a 2014 Joint Commission Sentinel Event Alert, which highlighted fatal errors from feeding solutions entering IV lines. The device is expected to impact NICUs across India.PR NewswireThe peripheral intravenous catheters market is expected to grow at a CAGR of over 4% during the period 2019-2025The global peripheral intravenous catheters market is projected to grow at a compound annual growth rate (CAGR) of over 4% during the period 2019–2025, driven by rising trauma cases, increasing chronic disease prevalence, and growing demand for safety catheters to reduce hospital-acquired infections. Key growth drivers include the shift toward safety PIVCs and midline IV catheters, which offer advantages such as reduced central line-associated bloodstream infections and decreased need for repeated venipunctures. The market is segmented by product type (short PIVC, midline IV catheter), technology (conventional, safety), and end-user (hospitals, specialty cardiac centers, ambulatory care settings), with major vendors including BD, Smiths Medical, Vygon, B. Braun Melsungen, Teleflex, and Terumo dominating the competitive landscape.FinSMEsVygon Acquires Advanced Perfusion DiagnosticsVygon acquired Advanced Perfusion Diagnostics, a French startup developing critical care monitoring solutions. The deal includes technology, patents, and staff onboarding, with financial terms undisclosed. APD's IKORUS device, which measures microvascular blood flow, received CE marking in June 2019.FinSMEsVygon Group Acquires PilotVygon Group acquired Pilot, an Italian ECG guidance device company, with undisclosed financial terms. The deal adds Vygon's ECG location and navigation technology to its intravascular therapy portfolio, with manufacturing and development handled at its Medwin site. Vygon distributes over 205 million products annually in 120+ countries.GlobeNewswireVigmed signs distribution agreement for the important markets in the United Kingdom and Ireland.Vigmed signed a distribution agreement with Vygon UK and Vygon Ireland, granting them exclusive rights to sell Vigmed products in the UK and Ireland. The deal covers all major EU markets, with Vygon's experience in IV-catheter and arterial access markets cited as a key factor.PR NewswireTip Location Devices Market: Global Industry Analysis and Opportunity Assessment, 2016-2026This Future Market Insights report examines the global tip location devices market for the period 2016-2026, providing market analysis, segmentation, and forecasts. The market is driven by increasing prevalence of chronic diseases such as cancer, leading to greater adoption of PICC (peripherally inserted central catheter) procedures for chemotherapy, antibiotics, and parenteral nutrition. Key market participants identified include C.R. Bard, Inc., Teleflex Incorporated, AngioDynamics Inc., Vygon S.A., and CORPAK MedSystems.PR NewswireTip Location Devices Market: Global Industry Analysis and Opportunity Assessment, 2016-2026Future Market Insights released a market research report examining the global tip location devices market for the period 2016–2026, segmented by product type, technology, end user, and region. The report identifies key market participants including C.R. Bard, Inc., Teleflex Incorporated, AngioDynamics Inc., Vygon S.A., and CORPAK MedSystems, and attributes market growth to increasing prevalence of chronic diseases such as cancer and rising adoption of PICC procedures globally.